Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2012; 18(3): 244-250
Published online Jan 21, 2012. doi: 10.3748/wjg.v18.i3.244
Published online Jan 21, 2012. doi: 10.3748/wjg.v18.i3.244
Figure 4 Effect of urokinase plasminogen activator inhibitor (B428) on KKU-M213 cell invasion.
Cell suspension in medium containing B428 (10 and 20 μmol/L) and 0.1% dimethyl sulfoxide (as a control) were subjected to in vitro invasion assay for 6 h. Cell survival was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay after cells were incubated with the drug for 6 h. The results were presented as mean ± SE from three independent experiments. Significant difference is indicated by aP < 0.05.
- Citation: Thummarati P, Wijitburaphat S, Prasopthum A, Menakongka A, Sripa B, Tohtong R, Suthiphongchai T. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. World J Gastroenterol 2012; 18(3): 244-250
- URL: https://www.wjgnet.com/1007-9327/full/v18/i3/244.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i3.244